Hypercell Technologies
Brookhaven, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into Hypercell Technologies
275 people in our graph share verified history with the Hypercell Technologies team — schools, employers, funds. One of them is your warm intro.
Sumant Mandalunlockedknows Brian McFarlane · together at Michigan State University (overlapped)
×3knows the team · via The Ohio State University
knows the team · via Colorado State University
knows the team · via Michigan State University
×3knows the team · via University of Arkansas
knows the team · via Environment and Climate Change Canada
Hypercell develops rapid on-site diagnostic tests that detect pathogens such as Salmonella and E. coli in the food supply chain, aiming to deliver both speed and lab-grade accuracy. It serves Fortune 100 food processors and food safety teams to help prevent contamination and reduce recalls, primarily in the U.S.
Founders & leadership
BM
Brian McFarlaneinChief Commercial OfficerBrian McFarlane has over 25 years of experience in food safety and protein production systems, having worked on supply chain optimization and technology commercialization for major food companies in the beef and pork sectors. He holds an affiliate staff position at Colorado State University and serves as Chief Commercial Officer at Hypercell Technologies.
LD
Loïc DeblaisinChief Science OfficerLoïc Deblais has held lab management and R&D scientist roles in microbiology and molecular biology, with experience in bioprocess optimization, quality assurance, and technology transfer in the agriculture and pharmaceutical sectors. He holds 3 patents and has authored multiple publications in his field.
SJ
Sam JactelCo-founder & Senior Advisor
BJ
Bruno JactelFounder
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2021
▶$1.1MraisedSep 2021 · 6 investors · Other TechnologyRule 506(b)
▶$1.1MraisedSep 2021 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sam JactelExecutive Officer, Director
- Bruno JactelExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.1M
- Minimum investment
- $1
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Hypercell Technologies do?
- Hypercell develops rapid on-site diagnostic tests that detect pathogens such as Salmonella and E. coli in the food supply chain, aiming to deliver both speed and lab-grade accuracy. It serves Fortune 100 food processors and food safety teams to help prevent contamination and reduce recalls, primarily in the U.S.
- Who are Hypercell Technologies's investors?
- Hypercell Technologies's investors include Serra Ventures.
- How much funding has Hypercell Technologies raised?
- Hypercell Technologies has disclosed $1.1M raised across 1 round.
- Where is Hypercell Technologies headquartered?
- Hypercell Technologies is headquartered in Brookhaven, US.